Beating cancer with Harm Reduction
4.2.2021 11:24:05 CET | news aktuell GmbH | Pressemelding
Almost one third of cancer cases in Europe are caused by smoking:
“Tobacco consumption continues to be the leading cause of preventable cancer, with 27% of all cancers attributed to tobacco use. By eliminating tobacco use, nine out every ten cases of lung cancer could be avoided.”[1]
It is therefore more important than ever to use all means at hand to minimize smoking rates. Tobacco harm reduction is rated as a very good opportunity to significantly reduce the number of smokers. That is why it has to be included in an impactful EU Beating Cancer plan:
“When it comes to smoking cessation, the EU Commission is once again concentrating on the 'quit or die' approach instead of creating a realistic addiction policy.", says Prof Heino Stöver from the German Institute for Addiction Research at the Frankfurt University of Applied Sciences. And further: “Great Britain, New Zealand and Canada are putting the e- Cigarette as a main tool in the fight against tobacco use and have been shown to be very successful.”[2]
Cancer potencies: 0.5% of the risk of smoking
In embracing harm reduction the UK shows a better and more effective strategy to decrease the number of smokers. With broad education on harm-reducing alternatives, British health policy has drastically reduced the smoking rate within a few years. In 2011, 20 percent of the British still smoked, in 2019 it was around 14 percent.[3]
In 2018, the government agency Public Health England (PHE) published a report with data on e-cigarettes. According to PHE, vapers have a 99.5 percent lower risk of cancer than smokers. Overall, PHE estimates that e-cigarettes are at least 95 percent less harmful than tobacco cigarettes.[4]
Dustin Dahlmann, Chairman of IEVA: “We welcome the EU Beating Cancer Plan. The strategy needs to consider all means available to reduce the burden of cancer related risks: It is of utmost importance that preventive measures are flanked by tobacco harm reduction. Otherwise, millions of smokers might miss the opportunity to tremendously reduce their risk of cancer.”
[1] EU Beating Cancer Plan, 2021. Link
[2] Prof Heino Stöver, Press release, February 03, 2021. Link
[3] Adult smoking habits in the UK: 2019. Link
[4] “Evidence review of e-cigarettes and heated tobacco products”, Public Health England 2018. Link
Kontakter
Independent European Vape Alliance (IEVA)
President: Dustin Dahlmann
Press coordinator: Philip Drögemüller
Phone: +32 (2) 791 7759
E-Mail: p.droegemueller@eurovape.eu
Web: www.eurovape.eu
Lenker
Om news aktuell GmbH
IEVA - Independent European Vape Alliance
The Independent European Vape Alliance (IEVA) is the only pan-European association aimed at uniting national associations, companies, manufacturers and wholesalers in the vaping industry and providing them with responsible representation at the European level.
IEVA’s founding principle is to contribute to harm reduction and public health. E-cigarettes have a significant positive impact and should be recognized as a harm reduction tool because vaping is not smoking.
Følg pressemeldinger fra news aktuell GmbH
Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra news aktuell GmbH
Major update for Thermomix® and Cookidoo®¬– ecosystem gets smarter, more personalised and more global21.9.2026 13:47:30 CEST | Press release
Thermomix® takes its ecosystem to the next level: With the new Cookidoo® Assistant and Recipe Translation benefits, the largest culinary community gains comprehensive AI features. In addition, Arabic is introduced as a new language option on Thermomix® TM7, following a long-standing community demand.
Grünenthal acquires cancer treatment Stivarga®21.9.2026 12:36:25 CEST | Press release
Latest step in Grünenthal’s strategy to acquire established medicines that serve clear medical needs, leverage its commercial and operational capabilities, and drive growth. Stivarga® (regorafenib) is an established oral treatment for certain advanced cancers, including metastatic colorectal cancer, gastrointestinal stromal tumours (GIST) and hepatocellular carcinoma (liver cancer). It is approved and available in more than 90 markets worldwide. Grünenthal has invested around €2.6 billion in successful M&A transactions since 2017, significantly strengthening its profitability and further funding its innovative research pipeline.
S&Ds to von der Leyen: Europe must deliver for people and strengthen its sovereignty16.9.2026 09:22:05 CEST | Press release
Strasbourg, 15 september 2026 Ahead of Commission President Ursula von der Leyen’s State of the Union address and debate in Strasbourg on September 16, 2026, the Socialists and Democrats in the European Parliament (S&D) call for a change of direction: away from deregulation and towards better living and working conditions for Europeans, tangible social justice, and a stronger, more sovereign Europe. Iratxe García Pérez, president of the S&D Group in the European Parliament, said: “Europe is facing a choice. Not simply between different policies or political parties, but between two very different visions of our future. One vision is built on fear, power without limits, nationalism and the rule of the strongest. The other vision is the Europe we believe in: a Europe that protects its people, defends democracy and international law, fights climate change, guarantees social rights and has the strength to decide its own future.”* A Europe that delivers for its people The S&D Group has deli
The Iranian People Receive the 2026 Freedom Prize15.9.2026 09:09:43 CEST | Press release
The Friedrich Naumann Foundation for Freedom awards its Freedom Prize 2026 to the courageous people of Iran who are fighting for freedom, civil rights and democracy.
SAFENet Expands: New members join European router and network technology alliance / Five companies from four countries join the alliance for Europe's technological sovereignty10.9.2026 13:21:27 CEST | Press release
The Sovereignty Alliance for European Network Technology (SAFENet) welcomes five new members: Genexis, IPmotion, MB connect line, Teldat and Waystream. The alliance is growing rapidly, expanding from four to nine European network technology companies just a few weeks after its founding. With this growth, the alliance significantly broadens its European base. Their shared goal: to strengthen Europe's technological capacity to act – and to ensure that European network technology is given the weight it deserves in Brussels and in national capitals.
I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.
Besøk vårt presserom

